Coeptis Therapeutics Hldgs I

13F holders, Q1 2024 (March 31)
21holders
$0.30avg. 13F price*

At the end of Q1 2024, 21 institutions reported holding Coeptis Therapeutics Hldgs I in their 13F filings. The largest holders were Armistice Capital, LLC ($901K), Creative Planning ($192K) and Meteora Capital, LLC ($133K).

Company
Coeptis Therapeutics Hldgs I
CUSIP
19207A108
Latest filing quarter
Q1 2026

History

Number of 13F holders

0510152025 Q1 2024: 21Q1 2024Q2 2024: 18Q2 2024Q3 2024: 15Q3 2024Q4 2024: 2Q4 2024Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025Q1 2026: 1Q1 2026

Total Exit/New Position Q1 2024

InstitutionsTotal Value
New Positions5$155K
Exits4$36K

Ownership 21 holders

Armistice Capital, LLC 0.02% Reduce -13.9% 3,030,269 $901K
Creative Planning 0.00% No change 645,104 $192K
Meteora Capital, LLC 0.02% New 446,251 $133K
Geode Capital Management, LLC 0.00% Add +3.5% 190,154 $57K
Vanguard Group Inc. 0.00% No change 108,709 $32K
Cambridge Investment Research Advisors, Inc. 0.00% No change 56,149 $17K
Arista Wealth Management, LLC 0.01% New 47,332 $14K
Sea Otter Advisors LLC 0.09% No change 45,000 $13K
Ionic Capital Management LLC 0.01% No change 45,000 $13K
Mint Tower Capital Management B.V. 0.02% No change 45,000 $13K
Virtu Financial LLC 0.00% Add +113.6% 33,797 $10K
ACT Advisors, LLC. 0.00% New 10,463 $3K
HRT Financial LP 0.00% New 11,870 $3K
Shaolin Capital Management LLC 0.00% No change 10,000 $3K
Tower Research Capital LLC (TRC) 0.00% Reduce -21.0% 9,642 $3K
Osaic Holdings, Inc. 0.00% New 8,700 $3K
Wolverine Asset Management LLC 0.00% No change 222 $66
Wells Fargo & Company 0.00% Add +1.6% 187 $56
Semmax Financial Advisors Inc. 0.00% No change 112 $40
Barclays PLC 0.00% No change 67 $20
JPMorgan Chase & Co. 0.00% Add +142.1% 46 $14

"% of holder's portfolio" is COEPTIS THERAPEUTICS HLDGS I's weight in each manager's 13F, not the share of Coeptis Therapeutics Hldgs I the manager owns.